Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07201506

Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-04-01

70

Participants Needed

2

Research Sites

66 weeks

Total Duration

On this page

Sponsors

I

Insel Gruppe AG, University Hospital Bern

Lead Sponsor

U

University of Bern

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is investigating whether using ultrasound directly inside the heart during ablation of heart rhythm disorders in the ventricles can reduce radiation exposure for patients. During an ablation, catheters are guided through the heart to treat the abnormal electrical signals. Usually, X-ray imaging (fluoroscopy) is used to see where the catheters are, which exposes both patients and hospital staff to radiation. The study is randomized and controlled: half of the participants will have the ablation with ultrasound inside the heart, and the other half will have the standard ablation without ultrasound during the procedure. The main goal is to compare the amount of X-ray time used during the procedure. Secondary goals are to look at safety, effectiveness, and the total procedure time. Patients with premature ventricular contractions or ventricular tachycardia can take part. A total of 70 people will be included, 35 in each group. Using ultrasound inside the heart makes it possible to see the catheters and heart structures directly, so many steps can be done without X-rays. This could make ablations safer and reduce radiation exposure. The study is being carried out at Inselspital, Bern University Hospital, and at University Hospital Basel. All steps are standardized and data are collected carefully. The results will show whether ultrasound during ablations can significantly reduce radiation and make ablations more efficient and safer.

CONDITIONS

Official Title

Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years or older undergoing a premature ventricular contraction or ventricular tachycardia ablation.
Not Eligible

You will not qualify if you...

  • Ventricular arrhythmia likely originating in the right ventricular outflow tract (left-bundle-inferior axis, >V4 precordial transition).
  • Planned primary epicardial ablation.
  • Presence of congenital heart disease.
  • Presence of a mechanical tricuspid valve prosthesis.
  • Unwilling or unable to fully comply with study procedures and follow-up.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University Hospital Basel

Basel, Switzerland, 4013

Actively Recruiting

2

Inselspital, Bern University Hospital

Bern, Switzerland, 3010

Actively Recruiting

Loading map...

Research Team

B

Boldizsar Kovacs, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here